Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus paracasei VPro 224 and Reduced Salivary Levels of Mutans Streptococci

Research synthesisModerate evidenceModerate effect4 studies · 4 beneficial · 0 neutral · 0 harmful

All 4 studies (4 randomized controlled trials) reported beneficial effects of Lactobacillus paracasei VPro 224 on reducing salivary mutans streptococci, with predominantly moderate effect sizes. Studies were conducted primarily in children (including preschool children) and young adults. No specific dose range was identified due to lack of reporting across studies.

  • Studied populations: Children (including preschool children) and healthy young adults (aged 20–26)

Caveats: Dose information was not reported in any of the included studies, limiting the ability to determine optimal intake. All studies used the SD1 strain; consistency with the VPro 224 designation is assumed but not confirmed.

Generated May 11, 2026
4 of 4 papers
Back to top